Amy GilesIncreasing Engagement
Joey CohenMedication Adherence
Frank BurrellScientific Storytelling
Brenda SnowAuthentic Patient Voice
Matthew DurhamOmnidynamic Marketing
Bud BilanichSuccess Coach
Liz KaneImpactful Strategy
Daniel SontupeMarket Access
Stacey GandlerBrand Nourishment
Suma Ramadas, PhDMedical Affairs
Pat PurcellMeeting Engagement
David LinetskyPoint-of-Care Marketing
Matt TurnerPatient Affordability
Paul TheisenPatient Acquisition
SALT LAKE CITY, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), ...
Two-part Phase 1/2a study of VBI-1901 to enroll patients with recurrent GBM Part A: ...
--As previously reported, study met primary endpoint of culture conversion (p<0.0001)-- --ALIS under FDA ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email